Everything You Ever Wanted to Know about Trichomonas

Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Sexual Health Association. This activity is supported by an independent education grant from Visby Medical.

Release date: April 11, 2023
Expiration date: April 11, 2024

Estimated time to complete activity: 1.0 hour

Computer system hardware/software requirements: Access to an Internet browser and a high speed Internet connection.

For additional information about the accreditation of this activity, please visit https://partnersed.com

Method of Participation and Request for Credit

Participation in this self-study activity should be completed in approximately 1.0 hour. To successfully complete this activity and receive CE credit, learners must follow these steps during the period from April 11, 2023 through April 11, 2024:

Review the objectives and disclosures
Study the educational content
Visit this link and create an account
Successfully complete activity post-test
Complete the activity evaluation

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate.

Target Audience

This activity is intended for physicians, physician assistants, registered nurses, and nurse practitioners.

Educational Objectives

Choose appropriate diagnostic testing strategies for trichomonas with high sensitivity and specificity (>90%)
Prescribe treatment for patients with trichomonas and their partners according to the updated 2021 CDC Treatment Guidelines
Answer patient questions with concise, comprehensible counseling messages
Assess risk factors for trichomonas and determine appropriate patients for screening according to the 2021 CDC guidelines

Faculty

Ina Park, MD
Associate Professor
Family Community Medicine
University of California
San Francisco School of Medicine

Denise Linton, DNS, FNP, FAANP
Professor (Retired)
University of Louisiana at Lafayette

Disclosure of Conflicts of Interest

PACE requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Ina Park, MD
Dr. Park has nothing to disclose.

Denise Linton, DNS, FNP, FAANP
Ms. Linton has nothing to disclose.

The PACE planners and others have nothing to disclose. The American Sexual Health Association planners and others have nothing to disclose.

Credit Designation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the American Sexual Health Association. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hours.

PA Continuing Medical Education

PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until April 30, 2024. PAs should only claim credit commensurate with the extent of their participation

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.